about 60%, while between 10% and 14% show either severe or advanced forms, 5, 6 in agreement with the prevalence in the global population. 7 It is well known that periodontitis is a complex inflammationbased disease with a multifactorial aetiology. The main cause of this inflammation is found in the pathogenic bacterial species that may influence the onset and progression of the disease in combination with risk factors as smoking, diabetes and stress, or genetic predisposition. 8 Although bacterial accumulation is the condition sine qua non for the insurgence of the inflammation, 9 it was demonstrated that there is no correlation between the amount of plaque and the severity of periodontitis. 10 This suggests that the host response and its genetic contribution is a key factor in developing the periodontal disease. A population study in more than 10 000 Swedish twin pairs revealed that the genetic contribution to the risk of periodontal disease is 39% in women and 33% in men, 11 and studies in adult twins have confirmed that the host susceptibility is influenced by genetic factors.
11-13
A gene can be present in the genome in different forms de- Most recently, a genome-wide association approach was used to identify new genetic risk factors for periodontal disease. Different suggestive loci were identified, [14] [15] [16] [17] but only few studies have shown genome-wide significant results associated to periodontal disease or to related phenotypes. [18] [19] [20] In Schaefer et al, association in a German population between aggressive periodontitis and rs1537415 in the glycosyltransferase gene GLT6D1 was reported. 19 In another study, genomewide significant signals were detected analysing periodontal complex traits derived from information on levels of periodon- 22 Briefly, a strong signal for genetic isolation and a high level of inner structure resulting in increased genetic similarity was reported.
Moreover, these villages showed a divergence time from the closest general population of about 150 generations ago (~1000 years).
Participants gave written informed consent and the ethics committee of IRCCS Burlo Garofolo/ethics committee of the University of Trieste approved the study (Prot. CE/V-78, 06/08/2007).
| Periodontal status assessment
Medical family and individual history was first recorded. All the adults were subjected to an accurate oral examination in which periodontal examinations included measurements of periodontal pocket depth, plaque index, bleeding on probing index, clinical attachment loss and gingival recession on all teeth using a periodontal probe PCP12 (HuFriedy, Chicago, IL, USA). Four sites on each tooth were assessed: mesial; buccal; distal; and lingual. Moreover, the overall number of teeth present in the mouth was recorded. An additional X-ray examination (panoramic radiography) was collected. Wisdom teeth were excluded.
Diagnosis was made following the criteria of the American
Academy of Periodontology 23 and subjects were then categorized as summarized in Table 1 .
| Sample collection and phenotype definition
A common group of controls composed by people without signs of periodontitis or gingivitis was defined. Then, patients with diagnosis of chronic periodontitis were classified into different categories:
'slight' (people that fell into group 3 or 4); 'severe' (group 5 or 6);
'localized' (group 3 or 5); and 'generalized' (groups 4 and 6). Finally, the last group was named 'all', which included all people affected with chronic periodontitis (groups 3-6). A total number of 224 subjects were excluded, including patients with clinical signs of gingivitis (n = 93), aggressive periodontitis (n = 10), edentulous (n = 93) and patients with incomplete data (n = 28).
| Genotyping and imputation
For each sample, DNA was extracted from peripheral blood and genotyping was carried out using Illumina 370k high density SNP array (Illumina, Inc., San Diego, CA, USA). Genotype imputation was conducted after standard QC using SHAPEIT2 for the phasing step 24 and IMPUTE2 for the imputation 25 using the 1000 Genomes phase I v3 reference set.
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| Statistical analysis
For statistical analysis, we treated the logistic trait (0 = controls, 1 = cases) as though it was quantitative, which corresponds to the Armitage Trend Test. We thus used a linear mixed model regression where the periodontitis status was the dependent variant while the SNP dosages were the independent variable. Sex, age and smoking status were included in the model as covariates. The genomic kinship matrix was used as random effect to take into account the nonindependence of the samples as they are coming from an isolated population. Genomic kinship was estimated using the ibs function from the GenABEL R package. Linear regression was conducted using MixABEL and the GRAMMAR+ method. 27 We considered significant all SNPs that exhibited P < 5 × 10 −8 . Odds ratios were assessed using standard logistic regression, as no method can estimate odds ratios when inbreeding is present, while standard errors for confidence intervals were derived using the corrected test statistic and the beta from the logistic regression.
| RE SULTS
The main features of participants are shown in Table 2 . The mean age of the study sample was 51.39 ± 16.22 (range 18-89 years); 44%
(n = 363) of the participants were males and 56% (n = 463) were females; 20% of subjects were current smokers.
In our sample, 160 subjects without signs of periodontitis or gingivitis formed the control group, while 442 were affected by chronic Case-control genome-wide association analysis on all these groups of periodontitis identified four SNPs significantly associated only to localized periodontitis. Figure 1 shows the Manhattan plot of the results on localized periodontitis across the genome. Results and detailed information for the significant SNPs are reported in Table 3 . Chr, chromosome number; CI, 95% confidence interval values; MAF, minor allele frequency; n, total number of samples used in the analysis; OR, odds ratio; P, P-value; SNPs, single nucleotide polymorphisms.
F I G U R E 1
First column reports the name of the SNP; the 2nd the chromosome number; the 3rd the position of the polymorphism expressed in base pairs; the 4th and the 5th the alternative and the coded allele respectively. Sixth column reports the frequency of the coded allele.
F I G U R E 2 Regional association plot for the top hit of genome-wide association study on periodontal disease. Plot made using the tool Locus Zoom. SNPs are plotted with their P values (as −log10 values) as a function of genomic position. Estimated recombination rate are plotted to reflect the local linkage disequilibrium structure around the associated SNPs. SNPs, single nucleotide polymorphisms
The best hit was on rs242016 (P = 1.5 × 10 −8 , OR = 3.7). In addition, rs242014 (P = 1.6 × 10 −8 , OR = 3.7), rs10491972 (P = 1. No significant associations were found for the other subclassifications of periodontitis (all, severe, slight, generalized).
The possible functional role of the identified SNPs was explored using Haploreg v4, 28 showing that rs242002 is located inside enhancer regions active in numerous tissues, suggesting an involvement in affecting gene expression (http://archive.broadinstitute.
org/mammals/haploreg/detail_v4.1.php?query=&id=rs242002).
| D ISCUSS I ON
This study investigated the association among different subtypes of chronic periodontal disease and SNPs thanks to a GWAS. The advantage of running a study in geographically isolated towns is that these populations are consequentially also genetically isolated; thus, they have a restricted environmental, phenotypic and genetic heterogeneity, and this helps to identify the impact of genetic variants on multifactorial diseases, such as periodontal disease. In the present study, association among SNPs and chronic periodontitis (distinguished in slight, severe, localized and generalized periodontitis) was performed, founding for the first time an association between SNPs into the EFCAB4B gene and localized chronic periodontitis.
The function of SNPs we identified is still unknown. rs242016
is a synonymous SNP, while rs242014, rs10491972 and rs242002
are intron variants. Ad showed from Haploreg v4, a possible involvement of rs242002 in gene expression could be hypothesized.
Little is known also about EFCAB4B. This gene, localized on 30 The Ca 2+ influx across these channels is important for the activation, proliferation and cytokine production of these cells. 31 Moreover, EFCAB4B is also largely expressed in minor salivary glands, as reported in the GTEX portal 32 ( Figure S1 ). Considering the saliva itself produces proteins with immune activator/modulator properties (reviewed in Fabian et al), 33 further studies will be needed to investigate its link with this protein.
The link between the expression of the EFCAB4B protein in these tissues and periodontitis should be investigated in further studies to find out if its presence can be useful to monitor the onset and progression of the disease.
Other GWAS studies found association between SNPs in EFCAB4B gene and other pathological inflammatory conditions such as in non-alcoholic fatty liver disease. 34 Moreover, it has already been investigated if certain polymorphisms of proteins involved in the inflammatory response may increase or decrease a person's risk for periodontitis. Many are the candidate gene studies that investigated alteration of genes encoding for inflammatory mediators that can be periodontitis-associated, such as IL-4, IL-6, tumour necrosis factor, etc.; [35] [36] [37] [38] that is, it was found that the polymorphism of the IL-1 gene cluster is associated with the severity of periodontitis in non-smokers, and moreover it distinguished patients affected by severe periodontitis from those with mild disease. 39 Periodontal disease is also itself a risk factor for other inflammatory diseases. Chronic inflammation of the periodontal tissues continuously releases into the circulation blood inflammatory mediators involved in the progression of diseases such as coronary heart disease, 40 diabetes, 41 pre-term birth and low birth weight infants. 42 The results of our study suggested a role for the EFCAB4B gene in localized periodontitis through the possible involvement of the inflammatory mechanism. It can be hypothesized that this gene can be crucial during the early stages of periodontal disease, when it is localized, influencing the beginning of the inflammation process but not when the disease becomes to be extensive.
To identify susceptible individuals in the early stages of the periodontitis, when bone loss is limited, it might be useful to the clinician to perform better preventive therapy and periodontal treatment.
Strengths and limitation of the study: The strengths of this study include a deep and detailed periodontal examination and that patients originated from geographically isolated towns. In fact, within the limitations of small sample size (for a GWAS), the advantage of conducting a GWAS in isolated populations is that it could allow the detection of genetic variation, which could require a much larger sample size. Moreover, this study provides a potential link between an inflammatory pathology, such as periodontal disease, and a still poorly studied protein. However, this study needs to be confirmed in other populations where both periodontal status and genetic data are available to enable replication.
In conclusion, even if it is not possible at this point to use the present results to diagnose chronic periodontitis, to the best of our knowledge the present investigation for the first time reported an association between SNPs in the EFCAB4B gene and chronic lo- 
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